miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer
出版年份 2018 全文链接
标题
miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer
作者
关键词
-
出版物
Oncogenesis
Volume 7, Issue 12, Pages -
出版商
Springer Nature
发表日期
2018-12-18
DOI
10.1038/s41389-018-0106-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages
- (2017) Canhua Jiang et al. IMMUNOBIOLOGY
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma
- (2017) Jian-Yang Ao et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells
- (2017) Jian Guo et al. ONCOLOGY REPORTS
- Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors
- (2017) Chong Jiang et al. Molecular Imaging
- MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer
- (2015) Di Chen et al. CANCER LETTERS
- Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential
- (2015) Chen Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats
- (2015) Ai-ping Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
- (2015) Wei Wang et al. Journal of Zhejiang University-SCIENCE B
- miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis
- (2015) Sumei Zhou et al. TUMOR BIOLOGY
- MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway
- (2015) Qian Jiang et al. TUMOR BIOLOGY
- MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway
- (2015) Sushmita Bose Nandy et al. Oncotarget
- miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
- (2015) Alessandra Cataldo et al. Oncotarget
- MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer
- (2015) Fangmei An et al. Journal of Clinical Medicine
- By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
- (2015) Annalisa Petrelli et al. Oncotarget
- MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem-like Cells and Breast Tumor Development
- (2014) L. Deng et al. CANCER RESEARCH
- CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells
- (2014) Debbie C Strachan et al. OncoImmunology
- MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene
- (2013) J Yang et al. ONCOGENE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2-mTOR Pathway
- (2012) W. Chen et al. CANCER RESEARCH
- Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action
- (2012) Mahboob Ul Hussain CELL AND TISSUE RESEARCH
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling
- (2012) C A Gebeshuber et al. ONCOGENE
- Colony stimulating factors and myeloid cell biology in health and disease
- (2012) John A. Hamilton et al. TRENDS IN IMMUNOLOGY
- miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages
- (2012) Mario Leonardo Squadrito et al. Cell Reports
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
- (2009) Ariadne Androulidaki et al. IMMUNITY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression
- (2009) Y P Luo et al. ONCOGENE
- Osteoporotic Fractures Are Associated with an 86-Base Pair Repeat Polymorphism in the Interleukin-1-Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin-1β Gene
- (2006) Bente L. Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started